AdvanSix Announces Second Quarter 2025 Financial Results
2Q25 Sales of
2Q25 Earnings Per Share of
2Q25 Cash Flow from Operations of
Second Quarter 2025 Summary
"Our resilient second quarter results reflect our collective organization's execution and the advantages of our business model and diverse product portfolio amid an evolving macro environment,” said Erin Kane, president and CEO of AdvanSix. “While we faced an earlier end to the spring domestic application season, earnings and cash flow improved sequentially from the first quarter driven by strong performance from our Plant Nutrients business. End market demand across the rest of our portfolio remains softer overall and we continue to navigate margin impact driven by higher raw material prices, namely natural gas and sulfur. We have a demonstrated track record of successfully performing through a multitude of environments and remain confident in our ability to deliver long-term value. We continue to progress on 45Q carbon capture tax credits with an additional
Summary second quarter 2025 financial results for the Company are included below:
($ in Thousands, Except Earnings Per Share) |
2Q 2025 |
|
2Q 2024 |
|
Variance |
Sales |
|
|
|
|
( |
Net Income |
31,371 |
|
38,927 |
|
(7,556) |
Diluted Earnings Per Share |
1.15 |
|
1.43 |
|
(0.28) |
Adjusted Diluted Earnings Per Share (1) |
1.24 |
|
1.55 |
|
(0.31) |
Adjusted EBITDA (1) |
55,675 |
|
78,141 |
|
(22,466) |
Adjusted EBITDA Margin % (1) |
|
|
|
|
(360) bps |
Cash Flow from Operations |
21,110 |
|
50,200 |
|
(29,090) |
Capital Expenditures |
28,265 |
|
33,495 |
|
(5,230) |
Free Cash Flow (1)(2) |
(7,155) |
|
16,705 |
|
(23,860) |
(1) See “Non-GAAP Measures” included in this press release for non-GAAP reconciliations |
|||||
(2) Net cash provided by operating activities less capital expenditures |
Sales of
Sales by product line and approximate percentage of total sales are included below:
($ in Thousands) |
2Q 2025 |
|
2Q 2024 (1) |
||||||||
|
Sales |
|
% of Total |
|
Sales |
|
% of Total |
||||
Nylon |
$ |
79,503 |
|
|
|
$ |
103,217 |
|
|
||
Caprolactam |
|
66,424 |
|
|
|
|
81,303 |
|
|
||
Plant Nutrients |
|
156,770 |
|
|
|
|
147,339 |
|
|
||
Chemical Intermediates |
|
107,325 |
|
|
|
|
121,620 |
|
|
||
Total |
$ |
410,022 |
|
|
|
$ |
453,479 |
|
|
||
(1) The Company transferred certain products between its Chemical Intermediates product line and its Plant Nutrients product line to align more closely with its current sales structure. Historical information has been reclassified to reflect these changes for all periods presented in the Consolidated Financial Statements. Total revenue amounts were not impacted for either period. |
Adjusted EBITDA of
Adjusted earnings per share of
Cash flow from operations of
Outlook
- Anticipate higher ammonium sulfate pricing in 3Q25 year-over-year reflecting strong fall fill program; however, typical North American ammonium sulfate seasonality expected to drive 3Q25 sequential domestic pricing decline
- Acetone spread over refinery grade propylene costs anticipated to be lower year-over-year, but expected to remain near cycle averages
- Navigating an extended downturn in the nylon cycle - focused on controllable levers to optimize performance
-
Expect Capital Expenditures of
to$135 in 2025, reflecting the planned progression of our SUSTAIN growth program, and refined execution timing to address critical enterprise risk mitigation$145 million -
Continue to expect pre-tax income impact of plant turnarounds to be
to$25 in 2025 versus approximately$30 million in 2024$58 million
"We are well-positioned as an American manufacturer of essential chemistries serving a diverse set of end market applications with alignment to domestic agriculture, manufacturing supply chains and energy markets. The current market backdrop is mixed overall with favorable underlying fundamentals in Plant Nutrients contrasted against an extended downturn in Nylon Solutions. While we anticipate typical North American ammonium sulfate seasonality, we are starting the third quarter with a strong fall fill program at higher pricing levels compared to the prior year. In Chemical Intermediates, acetone pricing over raw materials has moderated off 2024 multi-year highs but remains near cycle averages, as anticipated. In times of uncertainty, we're keenly focused on delivering on controllable levers. This includes taking a measured and disciplined approach to cost and cash management including tensioned prioritization of our base capital investments, and optimizing mix and production output for the most profitable parts of our business. We remain confident in the growth prospects for AdvanSix, and are committed to delivering long-term value to our shareholders,” concluded Kane.
Sustainability Report
The Company released its 2024 Sustainability Report. You can find the report and read more about all of the great work and initiatives across the organization at AdvanSix Sustainability. More recently, the Company was awarded a 2025 Gold rating for corporate social responsibility from EcoVadis, with our score placing us in the top three percent of all companies assessed.
Dividend
The Company's Board of Directors declared a quarterly cash dividend of
Conference Call Information
AdvanSix will discuss its results during its investor conference call today starting at 9:30 a.m. ET. To participate on the conference call, dial (844) 855-9494 (domestic) or (412) 858-4602 (international) approximately 10 minutes before the 9:30 a.m. ET start, and tell the operator that you are dialing in for AdvanSix’s second quarter 2025 earnings call. The live webcast of the investor call as well as related presentation materials can be accessed at http://investors.advansix.com. Investors can hear a replay of the conference call from 12 noon ET on Aug 1 until 12 noon ET on Aug 8 by dialing (877) 344-7529 (domestic) or (412) 317-0088 (international). The access code is 4066943.
About AdvanSix
AdvanSix is a diversified chemistry company that produces essential materials for our customers in a wide variety of end markets and applications that touch people’s lives. Our integrated value chain of our five
Forward Looking Statements
This release contains certain statements that may be deemed “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact, that address activities, events or developments that our management intends, expects, projects, believes or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements may be identified by words such as "expect," "anticipate," "estimate," “outlook,” "project," "strategy," "intend," "plan," "target," "goal," "may," "will," "should" and "believe" and other variations or similar terminology and expressions. Although we believe forward-looking statements are based upon reasonable assumptions, such statements involve known and unknown risks, uncertainties and other factors, many of which are beyond our control and difficult to predict, which may cause the actual results or performance of the Company to be materially different from any future results or performance expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to: general economic and financial conditions in the
Non-GAAP Financial Measures
This press release includes certain non-GAAP financial measures intended to supplement, not to act as substitutes for, comparable GAAP measures. Reconciliations of non-GAAP financial measures to GAAP financial measures are provided in this press release. Investors are urged to consider carefully the comparable GAAP measures and the reconciliations to those measures provided. Non-GAAP measures in this press release may be calculated in a way that is not comparable to similarly-titled measures reported by other companies.
AdvanSix Inc.
|
|||||||
|
June 30, 2025 |
|
December 31, 2024 |
||||
ASSETS |
|
|
|
||||
Current assets: |
|
|
|
||||
Cash and cash equivalents |
$ |
18,446 |
|
|
$ |
19,564 |
|
Accounts and other receivables – net |
|
159,702 |
|
|
|
145,673 |
|
Inventories – net |
|
221,764 |
|
|
|
212,386 |
|
Taxes receivable |
|
15,243 |
|
|
|
503 |
|
Other current assets |
|
19,021 |
|
|
|
8,990 |
|
Total current assets |
|
434,176 |
|
|
|
387,116 |
|
Property, plant and equipment – net |
|
936,309 |
|
|
|
917,858 |
|
Operating lease right-of-use assets |
|
136,888 |
|
|
|
153,438 |
|
Goodwill |
|
56,192 |
|
|
|
56,192 |
|
Intangible assets |
|
41,619 |
|
|
|
43,144 |
|
Other assets |
|
41,218 |
|
|
|
37,172 |
|
Total assets |
$ |
1,646,402 |
|
|
$ |
1,594,920 |
|
|
|
|
|
||||
LIABILITIES |
|
|
|
||||
Current liabilities: |
|
|
|
||||
Accounts payable |
$ |
231,907 |
|
|
$ |
228,761 |
|
Accrued liabilities |
|
48,200 |
|
|
|
47,264 |
|
Income taxes payable |
|
384 |
|
|
|
1,047 |
|
Operating lease liabilities – short-term |
|
38,718 |
|
|
|
42,493 |
|
Deferred income and customer advances |
|
1,858 |
|
|
|
37,538 |
|
Total current liabilities |
|
321,067 |
|
|
|
357,103 |
|
Deferred income taxes |
|
151,938 |
|
|
|
145,299 |
|
Operating lease liabilities – long-term |
|
99,037 |
|
|
|
111,400 |
|
Line of credit – long-term |
|
240,000 |
|
|
|
195,000 |
|
Other liabilities |
|
10,628 |
|
|
|
11,468 |
|
Total liabilities |
|
822,670 |
|
|
|
820,270 |
|
|
|
|
|
||||
STOCKHOLDERS' EQUITY |
|
|
|
||||
Common stock, par value |
|
332 |
|
|
|
330 |
|
Preferred stock, par value |
|
— |
|
|
|
— |
|
Treasury stock at par (6,308,099 shares at June 30, 2025; 6,252,129 shares at December 31, 2024) |
|
(63 |
) |
|
|
(63 |
) |
Additional paid-in capital |
|
140,097 |
|
|
|
136,872 |
|
Retained earnings |
|
677,354 |
|
|
|
631,541 |
|
Accumulated other comprehensive income |
|
6,012 |
|
|
|
5,970 |
|
Total stockholders' equity |
|
823,732 |
|
|
|
774,650 |
|
Total liabilities and stockholders' equity |
$ |
1,646,402 |
|
|
$ |
1,594,920 |
|
AdvanSix Inc.
|
|||||||||||||
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
||||||||||
|
|
2025 |
|
|
|
2024 |
|
|
2025 |
|
|
|
2024 |
Sales |
$ |
410,022 |
|
|
$ |
453,479 |
|
$ |
787,813 |
|
|
$ |
790,308 |
|
|
|
|
|
|
|
|
||||||
Costs, expenses and other: |
|
|
|
|
|
|
|
||||||
Costs of goods sold |
|
351,308 |
|
|
|
372,111 |
|
|
675,628 |
|
|
|
705,975 |
Selling, general and administrative expenses |
|
25,416 |
|
|
|
24,431 |
|
|
48,825 |
|
|
|
48,024 |
Interest expense, net |
|
2,255 |
|
|
|
3,514 |
|
|
3,796 |
|
|
|
6,213 |
Other non-operating (income) expense, net |
|
(607 |
) |
|
|
1,351 |
|
|
(1,015 |
) |
|
|
1,441 |
Total costs, expenses and other |
|
378,372 |
|
|
|
401,407 |
|
|
727,234 |
|
|
|
761,653 |
|
|
|
|
|
|
|
|
||||||
Income before taxes |
|
31,650 |
|
|
|
52,072 |
|
|
60,579 |
|
|
|
28,655 |
Income tax expense |
|
279 |
|
|
|
13,145 |
|
|
5,864 |
|
|
|
7,124 |
Net income |
$ |
31,371 |
|
|
$ |
38,927 |
|
$ |
54,715 |
|
|
$ |
21,531 |
|
|
|
|
|
|
|
|
||||||
Earnings per common share |
|
|
|
|
|
|
|
||||||
Basic |
$ |
1.17 |
|
|
$ |
1.45 |
|
$ |
2.04 |
|
|
$ |
0.80 |
Diluted |
$ |
1.15 |
|
|
$ |
1.43 |
|
$ |
2.01 |
|
|
$ |
0.79 |
|
|
|
|
|
|
|
|
||||||
Weighted average common shares outstanding |
|
|
|
|
|
|
|
||||||
Basic |
|
26,896,037 |
|
|
|
26,839,429 |
|
|
26,867,252 |
|
|
|
26,859,044 |
Diluted |
|
27,223,309 |
|
|
|
27,150,347 |
|
|
27,248,976 |
|
|
|
27,251,326 |
AdvanSix Inc.
|
|||||||||||||||
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
||||||||||||
|
|
2025 |
|
|
|
2024 |
|
|
|
2025 |
|
|
|
2024 |
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
||||||||
Net income |
$ |
31,371 |
|
|
$ |
38,927 |
|
|
$ |
54,715 |
|
|
$ |
21,531 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
|
|
||||||||
Depreciation and amortization |
|
19,461 |
|
|
|
19,162 |
|
|
|
38,639 |
|
|
|
38,264 |
|
(Gain) loss on disposal of assets |
|
33 |
|
|
|
172 |
|
|
|
(177 |
) |
|
|
261 |
|
Deferred income taxes |
|
2,592 |
|
|
|
(357 |
) |
|
|
6,646 |
|
|
|
751 |
|
Stock-based compensation |
|
2,309 |
|
|
|
2,193 |
|
|
|
4,287 |
|
|
|
4,404 |
|
Amortization of deferred financing fees |
|
154 |
|
|
|
154 |
|
|
|
309 |
|
|
|
309 |
|
Operational asset adjustments |
|
— |
|
|
|
1,200 |
|
|
|
— |
|
|
|
1,200 |
|
Changes in assets and liabilities, net of business acquisitions: |
|
|
|
|
|
|
|
||||||||
Accounts and other receivables |
|
19,658 |
|
|
|
(186 |
) |
|
|
(13,994 |
) |
|
|
(6,004 |
) |
Inventories |
|
1,093 |
|
|
|
15,094 |
|
|
|
(9,378 |
) |
|
|
36,004 |
|
Taxes receivable |
|
(15,188 |
) |
|
|
(171 |
) |
|
|
(14,740 |
) |
|
|
1,255 |
|
Accounts payable |
|
(6,939 |
) |
|
|
(8,686 |
) |
|
|
12,423 |
|
|
|
(61,681 |
) |
Income taxes payable |
|
(2,206 |
) |
|
|
72 |
|
|
|
(663 |
) |
|
|
(7,026 |
) |
Accrued liabilities |
|
5,510 |
|
|
|
3,999 |
|
|
|
561 |
|
|
|
6,149 |
|
Deferred income and customer advances |
|
(24,724 |
) |
|
|
(10,138 |
) |
|
|
(35,680 |
) |
|
|
(14,530 |
) |
Other assets and liabilities |
|
(12,014 |
) |
|
|
(11,235 |
) |
|
|
(10,395 |
) |
|
|
(6,889 |
) |
Net cash provided by operating activities |
|
21,110 |
|
|
|
50,200 |
|
|
|
32,553 |
|
|
|
13,998 |
|
|
|
|
|
|
|
|
|
||||||||
Cash flows from investing activities: |
|
|
|
|
|
|
|
||||||||
Expenditures for property, plant and equipment |
|
(28,265 |
) |
|
|
(33,495 |
) |
|
|
(62,327 |
) |
|
|
(68,883 |
) |
Other investing activities |
|
(3,159 |
) |
|
|
(2,317 |
) |
|
|
(5,891 |
) |
|
|
(3,736 |
) |
Net cash used for investing activities |
|
(31,424 |
) |
|
|
(35,812 |
) |
|
|
(68,218 |
) |
|
|
(72,619 |
) |
|
|
|
|
|
|
|
|
||||||||
Cash flows from financing activities: |
|
|
|
|
|
|
|
||||||||
Borrowings from line of credit |
|
113,000 |
|
|
|
73,000 |
|
|
|
231,500 |
|
|
|
257,500 |
|
Repayments of line of credit |
|
(88,000 |
) |
|
|
(88,000 |
) |
|
|
(186,500 |
) |
|
|
(197,500 |
) |
Principal payments of finance leases |
|
(244 |
) |
|
|
(263 |
) |
|
|
(491 |
) |
|
|
(502 |
) |
Dividend payments |
|
(4,290 |
) |
|
|
(4,292 |
) |
|
|
(8,580 |
) |
|
|
(8,582 |
) |
Purchase of treasury stock |
|
(51 |
) |
|
|
(3,362 |
) |
|
|
(1,537 |
) |
|
|
(10,385 |
) |
Issuance of common stock |
|
1 |
|
|
|
1 |
|
|
|
155 |
|
|
|
427 |
|
Net cash provided by (used for) financing activities |
|
20,416 |
|
|
|
(22,916 |
) |
|
|
34,547 |
|
|
|
40,958 |
|
|
|
|
|
|
|
|
|
||||||||
Net change in cash and cash equivalents |
|
10,102 |
|
|
|
(8,528 |
) |
|
|
(1,118 |
) |
|
|
(17,663 |
) |
Cash and cash equivalents at beginning of period |
|
8,344 |
|
|
|
20,633 |
|
|
|
19,564 |
|
|
|
29,768 |
|
Cash and cash equivalents at the end of period |
$ |
18,446 |
|
|
$ |
12,105 |
|
|
$ |
18,446 |
|
|
$ |
12,105 |
|
|
|
|
|
|
|
|
|
||||||||
Supplemental non-cash investing activities: |
|
|
|
|
|
|
|
||||||||
Capital expenditures included in accounts payable |
|
|
|
|
$ |
14,762 |
|
|
$ |
14,932 |
|
AdvanSix Inc.
|
|||||||||||||||
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
||||||||||||
|
|
2025 |
|
|
|
2024 |
|
|
|
2025 |
|
|
|
2024 |
|
Net cash provided by operating activities |
$ |
21,110 |
|
|
$ |
50,200 |
|
|
$ |
32,553 |
|
|
$ |
13,998 |
|
Expenditures for property, plant and equipment |
|
(28,265 |
) |
|
|
(33,495 |
) |
|
|
(62,327 |
) |
|
|
(68,883 |
) |
Free cash flow (1) |
$ |
(7,155 |
) |
|
$ |
16,705 |
|
|
$ |
(29,774 |
) |
|
$ |
(54,885 |
) |
|
|
|
|
|
|
|
|
||||||||
(1) Free cash flow is a non-GAAP measure defined as Net cash provided by operating activities less Expenditures for property, plant and equipment. |
|||||||||||||||
The Company believes that this metric is useful to investors and management as a measure to evaluate our ability to generate cash flow from business operations and the impact that this cash flow has on our liquidity. |
Reconciliation of Net Income to Adjusted EBITDA and Earnings Per Share to Adjusted Earnings Per Share |
|||||||||||||||
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
||||||||||||
|
|
2025 |
|
|
|
2024 |
|
|
|
2025 |
|
|
|
2024 |
|
Net income |
$ |
31,371 |
|
|
$ |
38,927 |
|
|
$ |
54,715 |
|
|
$ |
21,531 |
|
Non-cash stock-based compensation |
|
2,309 |
|
|
|
2,193 |
|
|
|
4,287 |
|
|
|
4,404 |
|
Non-recurring, unusual or extraordinary expense (2) |
|
— |
|
|
|
1,200 |
|
|
|
— |
|
|
|
1,200 |
|
Non-cash amortization from acquisitions |
|
531 |
|
|
|
532 |
|
|
|
1,063 |
|
|
|
1,064 |
|
Non-recurring M&A costs |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Income tax benefit relating to reconciling items |
|
(479 |
) |
|
|
(762 |
) |
|
|
(909 |
) |
|
|
(1,227 |
) |
Adjusted Net income (non-GAAP) |
|
33,732 |
|
|
|
42,090 |
|
|
|
59,156 |
|
|
|
26,972 |
|
Interest expense, net |
|
2,255 |
|
|
|
3,514 |
|
|
|
3,796 |
|
|
|
6,213 |
|
Income tax expense - Adjusted |
|
758 |
|
|
|
13,907 |
|
|
|
6,773 |
|
|
|
8,351 |
|
Depreciation and amortization - Adjusted |
|
18,930 |
|
|
|
18,630 |
|
|
|
37,576 |
|
|
|
37,200 |
|
Adjusted EBITDA (non-GAAP) |
$ |
55,675 |
|
|
$ |
78,141 |
|
|
$ |
107,301 |
|
|
$ |
78,736 |
|
|
|
|
|
|
|
|
|
||||||||
Sales |
$ |
410,022 |
|
|
$ |
453,479 |
|
|
$ |
787,813 |
|
|
$ |
790,308 |
|
|
|
|
|
|
|
|
|
||||||||
Adjusted EBITDA Margin (non-GAAP) (3) |
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
||||||||
(2) 2024 includes a pre-tax loss of approximately |
|||||||||||||||
(3) Adjusted EBITDA Margin is defined as Adjusted EBITDA divided by Sales |
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
||||||||
|
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
Net income |
$ |
31,371 |
|
$ |
38,927 |
|
$ |
54,715 |
|
$ |
21,531 |
Adjusted Net income (non-GAAP) |
|
33,732 |
|
|
42,090 |
|
|
59,156 |
|
|
26,972 |
|
|
|
|
|
|
|
|
||||
Weighted-average number of common shares outstanding - basic |
|
26,896,037 |
|
|
26,839,429 |
|
|
26,867,252 |
|
|
26,859,044 |
Dilutive effect of equity awards and other stock-based holdings |
|
327,272 |
|
|
310,918 |
|
|
381,724 |
|
|
392,282 |
Weighted-average number of common shares outstanding - diluted |
|
27,223,309 |
|
|
27,150,347 |
|
|
27,248,976 |
|
|
27,251,326 |
|
|
|
|
|
|
|
|
||||
EPS - Basic |
$ |
1.17 |
|
$ |
1.45 |
|
$ |
2.04 |
|
$ |
0.80 |
EPS - Diluted |
$ |
1.15 |
|
$ |
1.43 |
|
$ |
2.01 |
|
$ |
0.79 |
Adjusted EPS - Basic (non-GAAP) |
$ |
1.25 |
|
$ |
1.57 |
|
$ |
2.20 |
|
$ |
1.00 |
Adjusted EPS - Diluted (non-GAAP) |
$ |
1.24 |
|
$ |
1.55 |
|
$ |
2.17 |
|
$ |
0.99 |
The Company believes the non-GAAP financial measures presented in this release provide meaningful supplemental information as they are used by the Company’s management to evaluate the Company’s operating performance, enhance a reader’s understanding of the financial performance of the Company, and facilitate a better comparison among fiscal periods and performance relative to its competitors, as these non-GAAP measures exclude items that are not considered core to the Company’s operations. |
AdvanSix Inc.
|
||||||
|
1Q |
2Q |
3Q |
4Q |
FY |
Primary Unit Operation |
2017 |
— |
|
|
|
|
Sulfuric Acid |
2018 |
|
|
|
— |
|
Ammonia |
2019 |
— |
|
|
|
|
Sulfuric Acid |
2020 |
|
|
|
|
|
Ammonia |
2021 |
|
|
— |
|
|
Sulfuric Acid |
2022 |
|
|
|
— |
|
Ammonia |
2023 |
|
|
|
— |
|
Sulfuric Acid |
2024 |
|
|
|
|
|
Ammonia |
2025E |
|
|
— |
|
|
Sulfuric Acid |
(4) Primarily reflects the impact of fixed cost absorption, maintenance expense, and the purchase of feedstocks which are normally manufactured by the Company. |
||||||
(5) During the multi-site planned plant turnaround, additional required maintenance at our Frankford phenol plant contributed to reduced production across our integrated value chain and a delayed ramp to full operating rates at our |
||||||
(6) During the multi-site planned plant turnaround, additional required maintenance at our |
View source version on businesswire.com: https://www.businesswire.com/news/home/20250731943747/en/
Media
Janeen Lawlor
(973) 526-1615
janeen.lawlor@advansix.com
Investors
Adam Kressel
(973) 526-1700
adam.kressel@advansix.com
Source: AdvanSix